← Consumer Healthcare Products Association
FDARulemakingFDA-2023-N-4225

Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products

RIN
—
Last modified
Nov 28, 2025
Comment window
closed 488d ago
Consumer Healthcare Products Association filings
1

Activity

Consumer Healthcare Products Association filed 1 comment on this docket between Mar 28, 2025 and Mar 28, 2025. 5 other organizations filed here. The comment window closed 488d ago.

What Consumer Healthcare Products Association filed (1)

Mar 28, 2025· Comment from Consumer Healthcare Products Association (CHPA)· FDA-2023-N-4225-0119

Filed on regulations.gov — full text not in the inline record.

View on regulations.gov →

Abstract

The Food and Drug Administration (FDA, the Agency, or we) is proposing to require testing of talc-containing cosmetic products using standardized testing methods for detecting and identifying asbestos that may be present as a contaminant in talc. We are also proposing corresponding adulteration provisions. Asbestos is a potential contaminant in talc, which is used in certain cosmetic products, and is a known human carcinogen. This proposed rule, if finalized, will help protect users of talc-containing cosmetic products from harmful exposure to asbestos given the potential for contamination of these products.

View on regulations.gov →

Co-filers (5)

See everyone who commented →